A pilot randomized controlled trial of cognitive bias modification to reduce fear of breast cancer recurrence

201770 citationsJournal Articlebronze Open Access

Authors

Wendy G. Lichtenthal · Memorial Sloan Kettering Cancer Center

Geoffrey W. Corner · University of Southern California

Elizabeth Slivjak · Memorial Sloan Kettering Cancer Center

Kailey E. Roberts · Memorial Sloan Kettering Cancer Center

Yuelin Li · Memorial Sloan Kettering Cancer Center

William Breitbart · Memorial Sloan Kettering Cancer Center

Stephanie Lacey

Abstract

The results of the current pilot study suggest the promise of AIM-FBCR in reducing FCR in survivors of breast cancer. Future research should attempt to replicate these findings in a larger-scale trial using a more sophisticated, user-friendly program and additional measures of improvement in more diverse samples. Cancer 2017;123:1424-1433. © 2016 American Cancer Society.

Topics & Keywords

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Cancer

Volume 123, Issue 8, pp. 1424-1433

DOI: 10.1002/cncr.30478

Field-Weighted Citation Impact: 4.91